Clinical Study
Serum CA19-9 Level Associated with Metabolic Control and Pancreatic Beta Cell Function in Diabetic Patients
Table 3
Correlation analysis of serum CA19-9 with variables as follows.
| Variables | Serum CA19-9 | | |
| Age | 0.045 | 0.142 | Duration | 0.004 | 0.904 | ALT | 0.029 | 0.35 | AST | 0.038 | 0.217 | TC | 0.129** | <0.001 | TG | 0.048 | 0.125 | HDL | −0.002 | 0.961 | LDL | 0.068* | 0.028 | BUN | 0.057 | 0.07 | Cr | −0.064* | 0.041 | FPG | 0.309** | <0.001 | 2hFPG | 0.284** | <0.001 | HbA1c | 0.486** | <0.001 | GA | 0.389** | <0.001 | CP0 | −0.229** | <0.001 | CP120 | −0.365** | <0.001 | CP | −0.359** | <0.001 |
|
|
*, **.
|